^
    CANCER:

    Oral Cancer





    Show legend
    Group by Gene:
    Include preclinical:

    0
    PD1 inhibitor
    pembrolizumab
    nivolumab
    1
    Thymidylate synthase inhibitor
    5-fluorouracil
    capecitabine
    cetuximab
    		2
    EGFR inhibitor
    osimertinib
    gefitinib
    erlotinib
    3
    Tubulin polymerization promoter, Bcl2 inhibitor
    paclitaxel
    carboplatin + paclitaxel
    4
    DNA synthesis inhibitor
    cisplatin
    5
    THF dehydrogenase inhibitor, Dihydrofolic acid reductase inhibitor
    methotrexate
    6
    PD1 inhibitor, EGFR inhibitor
    pembrolizumab + cetuximab
    nivolumab + nimotuzumab
    7
    Multi-tyrosine kinase inhibitor
    pazopanib
    8
    PARP inhibitor
    olaparib
    9
    Microtubule stabilizer, Tubulin polymerization promoter
    docetaxel
    10
    HER2 inhibitor, HER4 inhibitor, EGFR inhibitor
    afatinib
    11
    Microtubule stabilizer, Tubulin polymerization promoter, DNA synthesis inhibitor
    cisplatin + docetaxel
    12
    Microtubule stabilizer, Tubulin polymerization promoter, DNA synthesis inhibitor, Thymidylate synthase inhibitor
    cisplatin + docetaxel + 5-fluorouracil
    13
    Tubulin polymerization promoter, Thymidylate synthase inhibitor
    carboplatin + 5-fluorouracil
    14
    DNA synthesis inhibitor, Thymidylate synthase inhibitor, Ribonucleotide reductase inhibitor
    5-fluorouracil + hydroxyurea
    15
    DNA synthesis inhibitor, Thymidylate synthase inhibitor
    cisplatin + 5-fluorouracil
    16
    Tubulin polymerization promoter, DNA synthesis inhibitor, Bcl2 inhibitor
    cisplatin + paclitaxel
    17
    Tubulin polymerization promoter, DNA synthesis inhibitor, Bcl2 inhibitor, Thymidylate synthase inhibitor
    cisplatin + paclitaxel + 5-fluorouracil
    18
    ATR inhibitor, PARP inhibitor
    ABT-888 + M6620
    19
    PD1 inhibitor, Multi-tyrosine kinase inhibitor
    nivolumab + MGCD516
    20
    Chemotherapy
    TPF
    21
    CDK4 inhibitor, CDK6 inhibitor
    palbociclib
    22
    pan-HER inhibitor
    CI-1033
    23
    HER2 inhibitor, EGFR inhibitor
    lapatinib
    24
    Src kinase inhibitor, FAK inhibitor
    AZD0530
    No biomarker
    PD-L1 overexpression
    PD-L1 expression
    EGFR wild-type
    FGFR2 P253R
    miR-1290-L
    GDF15 overexpression
    CHEK2 mutation
    BRCA2 mutation
    EGFR amplification
    PIK3CA H1047L
    HPRT1 overexpression
    LINC00963 overexpression
    CMTM6 overexpression
    EGF expression
    PIK3CA Q546R
    MME overexpression
    miR-155 overexpression
    FOXO3 underexpression
    POU5F1 overexpression + NANOG overexpression
    KRAS mutation